To further validate the mRNA and protein expression levels of the STAT1 signaling pathway downstream response genes in glioma tissues of different grades, qPCR and Western blotting of low-grade (WHO I/II) and high-grade (WHO III/IV) glioma groups were performed. This evidence concerns the gene STAT1 and central nervous system cancer.